Insights

Gathering insights about CytoSeek…

Similar companies to CytoSeek

CytoSeek Tech Stack

CytoSeek uses 8 technology products and services including jsDelivr, Squarespace, Webpack, and more. Explore CytoSeek's tech stack below.

jsDelivr
Content Delivery Network
Squarespace
Content Management System
Webpack
Development
Google Font API
Font Scripts
Modernizr
Javascript Libraries
jQuery
Javascript Libraries
Google
Search Engines
Google Analytics
Web Analytics

Media & News

Cytoseek hires Kevin Brady as Vice President of Preclinical Development.
CytoSeek Ltd, a discovery-stage biotech company developing the next generation of cell therapies to treat cancer using its Artificial Membrane-Binding Protein (AMBP) technology, is excited to announce the appointment of Kevin Brady as Vice President of Preclinical Development.
Nov 12, 2021 | www.cytoseek.uk
Cytoseek received financing of $4.84M in Seed on Mar 1st '21.
CytoSeek closed a seed financing round in March 2021 raising £3.6M to support the development of the AMBP platform for its internal cell therapy programs and the development and out-licence of its novel AMBP technology
Nov 12, 2021 | www.cytoseek.uk
Cytoseek is developing cell therapies to treat solid tumours.
University of Bristol biotech start-up CytoSeek has raised £3.5 million to develop new cell therapies to treat solid tumours in cancer patients.
Mar 16, 2021 | indiaeducationdiary.in
Cytoseek partners with University of Birmingham.
In collaboration with the University of Birmingham, CytoSeek is developing a new class of chimeric antigen receptor (CAR)-T cell that can attack solid tumours.
Sep 30, 2020 | www.pharmaceutical-technology.com
Cytoseek is developing class of chimeric antigen receptor -T cell that can attack solid tumours.
In collaboration with the University of Birmingham, CytoSeek is developing a new class of chimeric antigen receptor (CAR)-T cell that can attack solid tumours.
Sep 30, 2020 | www.pharmaceutical-technology.com
Cytoseek hired Carolyn Porter as chief executive officer on Jan 3rd '20.
Carolyn Porter has been named chief executive officer of CytoSeek Ltd, a discovery-stage biotech company developing the next generation of cell therapies to treat cancer with its pioneering cell-membrane augmentation technology.
Jan 23, 2020 | www.biospace.com
Cytoseek is developing next generation cell therapies.
CytoSeek Raise £1.1 Million for New Cell Therapies to Treat Solid Tumours Unit DX member CytoSeek has raised £1.1 million in funding to develop next generation cell therapies that could open new ways to treat solid tumours.
Nov 25, 2019 | unitdx.com

CytoSeek's Email Address Formats

CytoSeek uses at least 1 format(s):

CytoSeek Email Formats	Example	Percentage
First@cytoseek.uk	John@cytoseek.uk	50%
First@cytoseek.uk	John@cytoseek.uk	50%

Frequently Asked Questions

Where is CytoSeek's headquarters located?

CytoSeek's main headquarters is located at Bristol, Bristol BS8 GB. The company has employees across 1 continents, including Europe.

What is CytoSeek's official website and social media links?

CytoSeek's official website is cytoseek.uk and has social profiles on LinkedIn.

What is CytoSeek's NAICS code?

CytoSeek's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does CytoSeek have currently?

As of April 2025, CytoSeek has approximately 2 employees across 1 continents, including Europe. Key team members include Chief Executive Officer: B. C.Senior Researcher: T. G.Senior Protein Scientist: J. B.. Explore CytoSeek's employee directory with LeadIQ.

What industry does CytoSeek belong to?

CytoSeek operates in the Research Services industry.

What technology does CytoSeek use?

CytoSeek's tech stack includes jsDelivrSquarespaceWebpackGoogle Font APIModernizrjQueryGoogleGoogle Analytics.

What is CytoSeek's email format?

CytoSeek's email format typically follows the pattern of . Find more CytoSeek email formats with LeadIQ.

How much funding has CytoSeek raised to date?

As of April 2025, CytoSeek has raised $5M in funding. The last funding round occurred on Mar 16, 2021 for $5M.

When was CytoSeek founded?

CytoSeek was founded in 2017.

CytoSeek

Research ServicesBristol, United Kingdom2-10 Employees

CytoSeek's mission is to use cell membrane augmentation technology to unlock the potential of next generation advanced therapies.

Our novel cell membrane augmentation technology enables us to add new functionalities to various therapeutic cells. 

CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health.